Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hayden Locke, CEO Emmerson plc, a low cost high margin potash investment
Richard Slape, Oil consultant - Avoiding Losers and Picking Winners, his personal strategy


ShareCast News


Hikma Pharmaceuticals director buys-in after full-year results

Thu, 14th Mar 2019 16:24


(Sharecast News) - One of Hikma Pharmaceuticals's directors picked-up some shares in the company the day after its latest full-year numbers.

On Thursday, Dr. Pamela Kirby, a non-executive director at the non-branded generic and in-licensed pharmaceutical products maker, purchased 1,500 shares, on the market, at 1,586p apiece for a total transaction amount of £23,790.

The day before, Hikma had posted a 7% increase in full-year 2018 core revenues to $2.08bn with core operating profit up by 19% at $460m, but its sales were 1% below the average analyst forecast and profit was 2% light.

Core basic earnings per share, however, increased 31% to 137.8 cents, beating the consensus by 2% due to lower finance charges, while cash-flow from operating activities of $430m down from $443m.

Her purchase followed others by the executive chairman and vice-chairman, Said Darwazah and Mazen Darwazah, respectively, also the day before.

Analysts at Numis described the company's results as "strong" but said consensus estimates might be set for "modest downgrades".

"The shares aren't particularly cheap and conditions in US generics remain volatile and with the shares trading on 11 times's EV/EBITDA we stick with the 'hold' rating."

Top Director Buys

Hikma Pharmaceuticals (HIK)

Director name: Kirby,Pamela

Amount purchased: 1,500 @ 1,586.00p

Value: £23,790.00

4d Pharma (DDDD)

Director name: Stevenson,Alexander James

Amount purchased: 24,896 @ 91.50p

Value: £22,779.84

Haydale Graphene Industries (HAYD)

Director name: Humm,Roger James

Amount purchased: 841,432 @ 2.00p

Value: £16,828.64

Haydale Graphene Industries (HAYD)

Director name: Broadbent,Keith

Amount purchased: 500,000 @ 2.00p

Value: £10,000.00

Haydale Graphene Industries (HAYD)

Director name: Banks,David

Amount purchased: 500,000 @ 2.00p

Value: £10,000.00

Haydale Graphene Industries (HAYD)

Director name: Redman-Thomas,Laura

Amount purchased: 375,000 @ 2.00p

Value: £7,500.00

4d Pharma (DDDD)

Director name: Peyton,Duncan Joseph

Amount purchased: 6,770 @ 92.00p

Value: £6,228.40

React Group (REAT)

Director name: Joyce,Michael

Amount purchased: 2,000,000 @ 0.27p

Value: £5,340.00

React Group (REAT)

Director name: Joyce,Michael

Amount purchased: 1,000,000 @ 0.27p

Value: £2,670.00

Kcom Group (KCOM)

Director name: Bielby,Anna

Amount purchased: 217 @ 69.18p

Value: £150.12

Zotefoams (ZTF)

Director name: Stirling,David

Amount purchased: 25 @ 599.00p

Value: £149.75

Zotefoams (ZTF)

Director name: McGrath ,Gary

Amount purchased: 25 @ 599.00p

Value: £149.75



Top Director Sells

Record (REC)

Director name: Wood-Collins,James

Amount sold: 146,716 @ 28.70p

Value: £42,107.49





Back to ShareCast News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.